Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Extreme Makeover: Clinical Trials Edition
Posted on December 4th, 2017 by Sherry Winter in Pharma R&D
In a piece featured in the PharmaTimes, Katrina Megget points out the sad state of affairs when it comes to clinical trials, highlighting some appalling stats on the frequent failure to reach enrollment targets (in some cases, not finding any patients at all) and the tendency for studies to go on far longer than anticipated. (more…)
As Drug Development Costs Skyrocket, AI Offers Some Hope
Posted on November 20th, 2017 by Betsy Davis in Pharma R&D
Last year, researchers from the Tufts Center for the Study of Drug Development published a paper in the Journal of Health Economics that provided an assessment of the current cost for pharmaceutical companies to discover and develop new drugs and biologics. (more…)
Myelo Therapeutics Takes on Unmet Needs in Cancer
Posted on November 17th, 2017 by Betsy Davis in Pharma R&D
Many pharmaceutical and biotechnology start-ups have been founded for the purpose of taking on unmet needs. It has often been difficult for the larger, more established pharma companies to focus on these narrower problems, so the leaner, scrappier start-ups are putting their passion and brainpower to the challenges that have yet to be tackled. (more…)
Disrupting innovation: From geography, penguins and ocean currents to diagnosing disease by its smell
Posted on November 15th, 2017 by Dr Andrew A. Parsons in Pharma R&D
How to become aware of what I don’t know? These insights can stimulate disruption. They help us see a whole new world or perhaps a pattern of activities that need to change. As Donald Rumsfeld described, it is those things we don’t know we don’t know that can be issues for the future. They can also be lost opportunities in scientific understanding and commercial success. (more…)
